EVs drive resistance through diverse mechanisms that compromise immune cell function and enhance tumor survival: (1) Immune suppression via cargo transfer, TDEVs deliver immuno suppressive molecules (e.g., TGF-β, adenosine) to expand Tregs and MDSCs, creating an inhibitory TME. The gene discussed is TGFB1; the disease is neoplasm.